For research use only. Not for therapeutic Use.
TBK1/IKKε-IN-2 is a dual TBK1 and IKKε inhibitor.
Catalog Number | I013863 |
CAS Number | 1292310-49-6 |
Molecular Formula | C₂₆H₂₇N₅O₃ |
Purity | ≥95% |
Target | IKK |
Solubility | DMSO: 21.5 mg/mL |
IUPAC Name | 5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile |
InChI | InChI=1S/C26H27N5O3/c27-18-20-17-19(1-6-25(20)34-23-8-13-32-14-9-23)24-7-10-28-26(30-24)29-21-2-4-22(5-3-21)31-11-15-33-16-12-31/h1-7,10,17,23H,8-9,11-16H2,(H,28,29,30) |
InChIKey | BWABTWGSXHTHCG-UHFFFAOYSA-N |
SMILES | C1COCCC1OC2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCOCC5)C#N |
Reference | [1]. Muvaffak A, et al. Evaluating TBK1 as a therapeutic target in cancers with activated IRF3. Mol Cancer Res. 2014 Jul;12(7):1055-66. |